| Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. FN DD, L Leon, A Mucientes, L Rodriguez-Rodriguez, JI Colomer, ... Annals of the rheumatic diseases 79 (11), 1393-1399, 2020 | 149* | 2020 |
| Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases DDF Nuñez, L Leon, A Mucientes, L Rodriguez-Rodriguez, JF Urgelles, ... Annals of the Rheumatic Diseases 79 (11), 1393-1399, 2020 | 106 | 2020 |
| Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis R Redondo-Rodriguez, N Mena-Vázquez, AM Cabezas-Lucena, ... Journal of Clinical Medicine 11 (9), 2573, 2022 | 44 | 2022 |
| Altered expression of Wnt signaling pathway components in osteogenesis of mesenchymal stem cells in osteoarthritis patients P Tornero-Esteban, A Peralta-Sastre, E Herranz, L Rodríguez-Rodríguez, ... PLoS One 10 (9), e0137170, 2015 | 44 | 2015 |
| Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents B Fernandez-Gutierrez, L Leon, A Madrid, L Rodriguez-Rodriguez, ... Therapeutic Advances in Musculoskeletal Disease 13, 1759720X20962692, 2021 | 26 | 2021 |
| RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients JR Lamas, B Fernandez-Gutierrez, A Mucientes, F Marco, Y Lopiz, ... Arthritis research & therapy 21, 1-10, 2019 | 17 | 2019 |
| Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases L Leon, I Perez-Sancristobal, A Madrid, L Lopez-Pedraza, JI Colomer, ... Rheumatology Advances in Practice 6 (1), rkac008, 2022 | 16 | 2022 |
| Influence of mesenchymal stem cell sources on their regenerative capacities on different surfaces A Mucientes, E Herranz, E Moro, A González-Corchón, MJ Peña-Soria, ... Cells 10 (2), 481, 2021 | 13 | 2021 |
| Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease N Mena-Vázquez, FJ Godoy-Navarrete, JM Lisbona-Montañez, ... International Journal of Molecular Sciences 24 (7), 6800, 2023 | 11 | 2023 |
| Specific association of IL17A genetic variants with panuveitis A Mucientes, A Márquez, M Cordero-Coma, JM Martín-Villa, ... British Journal of Ophthalmology 99 (4), 566-570, 2015 | 11 | 2015 |
| Inflammatory profile of incident cases of late-onset compared with young-onset rheumatoid arthritis: A nested cohort study N Mena-Vázquez, JM Lisbona-Montañez, R Redondo-Rodriguez, ... Frontiers in Medicine 9, 1016159, 2022 | 9 | 2022 |
| miRNA-Mediated Epigenetic Regulation of Treatment Response in RA Patients—A Systematic Review A Mucientes, JM Lisbona, N Mena-Vázquez, P Ruiz-Limón, ... International Journal of Molecular Sciences 23 (21), 12989, 2022 | 9 | 2022 |
| Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis A Mucientes, B Fernández-Gutiérrez, E Herranz, L Rodriguez-Rodriguez, ... Clinical Rheumatology 38, 1329-1337, 2019 | 9 | 2019 |
| Adiposity is associated with expansion of the genus Dialister in rheumatoid arthritis patients N Mena-Vázquez, P Ruiz-Limón, I Moreno-Indias, S Manrique-Arija, ... Biomedicine & Pharmacotherapy 160, 114388, 2023 | 8 | 2023 |
| Importance of vaccination against SARS-coV-2 in patients with interstitial lung disease associated with systemic autoimmune disease N Mena-Vázquez, A García-Studer, M Rojas-Gimenez, CM Romero-Barco, ... Journal of Clinical Medicine 11 (9), 2437, 2022 | 8 | 2022 |
| Lessons from tofacitinib in patients with cardiovascular risk factors: increased pulmonary embolism or isolated (thrombotic) pulmonary occlusion rates? T Dörner Annals of the Rheumatic Diseases 79 (11), 1389-1392, 2020 | 5 | 2020 |
| Hospital admissions in inflammatory rheumatic diseases during the COVID-19 pandemic: incidence and role of disease modifying agents B Fernandez-Gutierrez, L Leon, A Madrid, L Rodriguez-Rodriguez, ... medRxiv, 2020.05. 21.20108696, 2020 | 5 | 2020 |
| Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients JR Lamas, A Mucientes, C Lajas, B Fernández-Gutiérrez, Y Lópiz, ... Immunotherapy 11 (13), 1107-1116, 2019 | 5 | 2019 |
| Differential Expression of HOX Genes in Mesenchymal Stem Cells from Osteoarthritic Patients Is Independent of Their Promoter Methylation A Mucientes, E Herranz, E Moro, C Lajas, G Candelas, ... Cells 7 (12), 244, 2018 | 5 | 2018 |
| Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study DF Nuñez, L Leon, AM Garcia, JIC Arce, A Mucientes, ... Therapeutic Advances in Musculoskeletal Disease 14, 1759720X221090296, 2022 | 4 | 2022 |
